Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40


The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Vallvé JC, Ferré R, Heras M, Rodríguez-Calvo R, Guaita-Esteruelas S, Martínez-Micaelo N, Plana N, Masana L.

J Clin Med. 2019 Oct 26;8(11). pii: E1793. doi: 10.3390/jcm8111793.


HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.


MicroRNA differential expression shared between rheumatoid arthritis and acute myocardial infarction: an exploratory study.

Paredes S, Taverner D, Ferré R, Alegret JM, Masana L, Vallvé JC.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):886-887. Epub 2019 Jun 3. No abstract available.


Assessment of arterial stiffness variables in patients with rheumatoid arthritis: A mediation analysis.

Taverner D, Paredes S, Ferré R, Masana L, Castro A, Vallvé JC.

Sci Rep. 2019 Mar 14;9(1):4543. doi: 10.1038/s41598-019-41069-5.


The Obemat2.0 Study: A Clinical Trial of a Motivational Intervention for Childhood Obesity Treatment.

Luque V, Feliu A, Escribano J, Ferré N, Flores G, Monné R, Gutiérrez-Marín D, Guillen N, Muñoz-Hernando J, Zaragoza-Jordana M, Gispert-Llauradó M, Rubio-Torrents C, Núñez-Roig M, Alcázar M, Ferré R, Basora JM, Hsu P, Alegret-Basora C, Arasa F, Venables M, Singh P, Closa-Monasterolo R.

Nutrients. 2019 Feb 16;11(2). pii: E419. doi: 10.3390/nu11020419.


Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.

Rodríguez M, Guardiola M, Oliva I, Carles Vallvé J, Ferré R, Masana L, Parra S, Ribalta J, Castro A.

Int J Rheum Dis. 2019 Mar;22(3):480-487. doi: 10.1111/1756-185X.13445. Epub 2018 Nov 18.


Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.

Plana N, Rodríguez-Borjabad C, Ibarretxe D, Ferré R, Feliu A, Caselles A, Masana L; en representación del proyecto DECOPIN.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):170-178. doi: 10.1016/j.arteri.2017.12.003. Epub 2018 Mar 27. English, Spanish.


Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.

Taverner D, Vallvé JC, Ferré R, Paredes S, Masana L, Castro A.

PLoS One. 2018 Mar 1;13(3):e0193690. doi: 10.1371/journal.pone.0193690. eCollection 2018.


Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.


Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.

Masana L, Girona J, Ibarretxe D, Rodríguez-Calvo R, Rosales R, Vallvé JC, Rodríguez-Borjabad C, Guardiola M, Rodríguez M, Guaita-Esteruelas S, Oliva I, Martínez-Micaelo N, Heras M, Ferré R, Ribalta J, Plana N.

J Clin Lipidol. 2018 Mar - Apr;12(2):292-299.e3. doi: 10.1016/j.jacl.2017.12.018. Epub 2018 Jan 8. Review.


[Long-term effects of continuous positive airway pressure treatment on subclinical atherosclerosis in obstructive sleep apnoea syndrome].

Català R, Ferré R, Cabré A, Girona J, Porto M, Texidó A, Masana L.

Med Clin (Barc). 2016 Jul 1;147(1):1-6. doi: 10.1016/j.medcli.2016.03.032. Spanish.


Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Ibarretxe D, Girona J, Amigó N, Plana N, Ferré R, Guaita S, Mallol R, Heras M, Masana L.

J Clin Lipidol. 2016 Mar-Apr;10(2):330-8.e2. doi: 10.1016/j.jacl.2015.12.012. Epub 2015 Dec 22.


[Intraabdominal fat redistribution in long-term continuous positive airway pressure treatment in obstructive sleep apnea patients].

Català R, Ferré R, Sangenís S, Cabré A, Hernández-Flix S, Masana L.

Med Clin (Barc). 2016 Jun 3;146(11):484-7. doi: 10.1016/j.medcli.2015.12.010. Epub 2016 Feb 17. Spanish.


Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.

Ibarretxe D, Girona J, Plana N, Cabré A, Ferré R, Amigó N, Guaita S, Mallol R, Heras M, Masana L.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):71-8. doi: 10.1016/j.arteri.2015.11.001. Epub 2015 Dec 29.


Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.

Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT Study Group.

J Hypertens. 2016 Jan;34(1):139-48. doi: 10.1097/HJH.0000000000000767.


Effect of Functional Bread Rich in Potassium, γ-Aminobutyric Acid and Angiotensin-Converting Enzyme Inhibitors on Blood Pressure, Glucose Metabolism and Endothelial Function: A Double-blind Randomized Crossover Clinical Trial.

Becerra-Tomás N, Guasch-Ferré M, Quilez J, Merino J, Ferré R, Díaz-López A, Bulló M, Hernández-Alonso P, Palau-Galindo A, Salas-Salvadó J.

Medicine (Baltimore). 2015 Nov;94(46):e1807. doi: 10.1097/MD.0000000000001807.


Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk.

Merino J, Sala-Vila A, Kones R, Ferre R, Plana N, Girona J, Ibarretxe D, Heras M, Ros E, Masana L.

J Nutr Biochem. 2014 Jun;25(6):642-6. doi: 10.1016/j.jnutbio.2014.02.004. Epub 2014 Mar 12.


Low-carbohydrate, high-protein, high-fat diet alters small peripheral artery reactivity in metabolic syndrome patients.

Merino J, Kones R, Ferré R, Plana N, Girona J, Aragonés G, Ibarretxe D, Heras M, Masana L.

Clin Investig Arterioscler. 2014 Mar-Apr;26(2):58-65. doi: 10.1016/j.arteri.2013.11.004. Epub 2013 Dec 21.


Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.

Català R, Cabré A, Hernández-Flix S, Ferré R, Sangenís S, Plana N, Texidó A, Masana L.

Sleep. 2013 Dec 1;36(12):1831-7. doi: 10.5665/sleep.3210.


Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages.

Lázaro I, Ferré R, Masana L, Cabré A.

Atherosclerosis. 2013 Oct;230(2):216-22. doi: 10.1016/j.atherosclerosis.2013.07.043. Epub 2013 Aug 1.


Supplemental Content

Loading ...
Support Center